Hemoglobin heme iron site (Hb-heme)

The hemoglobin heme iron site is the primary coordination center within red blood cells responsible for the transport of respiratory gases (Wikipedia, 2024). It consists of a ferrous (Fe2+) iron atom centered in a protoporphyrin IX ring, which reversibly binds oxygen for delivery to tissues (Britannica, 2026). This site is a critical therapeutic target in conditions where gas transport is impaired, such as carbon monoxide poisoning, where CO competitively inhibits oxygen binding (UMaryland, 2025), and methemoglobinemia, where iron oxidation to the ferric (Fe3+) state prevents oxygen carriage (NIH, 2025). Additionally, the site's affinity for oxygen is a target for allosteric modulators like voxelotor, which was designed to treat sickle cell disease by stabilizing the oxygenated state of hemoglobin to prevent polymerization (NIH, 2025). Understanding the redox and coordination chemistry of this site is essential for managing various hematological and toxicological disorders (Medscape, 2025).

Other names

Heme ironFerrous iron siteOxygen-binding site of hemoglobinHeme pocketIron-protoporphyrin IX site

Drugs targeting the hemoglobin heme iron site function through competitive ligand binding, redox state modulation, or allosteric regulation of oxygen affinity. Oxygen acts as a competitive ligand to displace carbon monoxide in poisoning cases (UMaryland, 2025). Methylene blue serves as an electron donor to reduce ferric iron (Fe3+) back to the functional ferrous state (Fe2+) in methemoglobinemia (NIH, 2025). Allosteric modulators like voxelotor bind to the globin chains to stabilize the high-oxygen-affinity R-state, thereby indirectly preventing the polymerization of deoxygenated sickle hemoglobin (NIH, 2025).